Company: RILYN
Filing Date: 2025-02-21
Form Type: 10-Q
Source: 0001628280-25-007082
Chunk: 38

Company: B. Riley Financial, Inc.
Filing Date: 2025-02-21
Form: 10-Q
Item: Part I, Item 1
Chunk 38
---
losses) on investments, $(259,260) of fair value adjustments on loans included in fair value adjustments on loans, and $2,057 related to contingent consideration included in selling, general and administrative expenses in the condensed consolidated statement of operations. Fair value adjustments during the nine months ended September 30, 2023 includes the following: $5,017 of realized and unrealized gains (losses) on equity securities is comprised of $11,573 relating to equity securities included in trading (loss) income and $(6,556) of realized and unrealized gains (losses) included in other income (loss) - realized and unrealized gains (losses) on investments, $51,624 of 

24

fair value adjustments on loans included in fair value adjustments on loans, and $(4,556) related to contingent consideration included in selling, general and administrative expenses in the condensed consolidated statement of operations. (2) - For the nine months ended September 30, 2024 and 2023, the change in unrealized gains (losses) is related to financial instruments held at the end of each respective reporting period. The carrying amounts reported in the condensed consolidated financial statements for cash and cash equivalents, restricted cash, accounts receivable, accounts payable and accrued expenses and other liabilities approximate fair value based on the short-term maturity of these instruments.As of September 30, 2024 and December 31, 2023, the senior notes payable had a carrying amount of $1,529,560 and $1,668,021, respectively, and fair value of $727,965 and $1,127,503, respectively. The aggregate carrying amount of the Company's notes payable, revolving credit facility, and term loans of $534,246 and $688,343 as of September 30, 2024 and December 31, 2023, respectively, approximates fair value because the effective yield of such instrument is consistent with current market rates of interest for instruments of comparable credit risk.The investments in nonpublic entities that do not report NAV are measured at cost, adjusted for observable price changes and impairments, with changes recognized in realized and unrealized gains (losses) on investments on the condensed consolidated statements of operations. These investments are evaluated on a nonrecurring basis based on the observable price changes in orderly transactions for the identical or similar investment of the same issuer. Further adjustments are not made until another observable transaction occurs. Therefore, the determination of fair values of these investments in nonpublic